2005
DOI: 10.2174/138920205775067710
|View full text |Cite
|
Sign up to set email alerts
|

Two Strategies to Identify Genes Underlying Complex Diseases

Abstract: Dissecting the genetic basis of complex diseases remains one of great challenges in human genetics, because these diseases have polygenic determinations and involve multiple gene-gene and gene-environmental interactions. Definite conclusions about finding genes underlying complex diseases need substantial evidence from three levels of gene function. The traditional strategy of gene identification is to determine putative susceptibility genes on the DNA level, and then to find related association between suscep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2012
2012

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 48 publications
(64 reference statements)
0
1
0
Order By: Relevance
“…Candidate QTL can be determined at each of these levels by using the respective methods: association and linkage, at the DNA level; genome-wide gene expression microarrays, at the mRNA level; and proteomics, at the protein level. Identification of the QTL for menarcheal age may follow either forward (DNA RNA protein) or backward (protein RNA DNA) strategies but the latter looks more promising because it provides a possibility for systemic analysis of the gene expression, respective regulatory networks, and effect of genegene and gene-environment interactions on the onset of a complex trait (Lei et al, 2005). Ultimately, such a combined approach should open a new avenue in the efforts towards determining a genetic basis of menarche and its timing.…”
Section: Prospects For Research On Genetics Of Age At Menarchementioning
confidence: 99%
“…Candidate QTL can be determined at each of these levels by using the respective methods: association and linkage, at the DNA level; genome-wide gene expression microarrays, at the mRNA level; and proteomics, at the protein level. Identification of the QTL for menarcheal age may follow either forward (DNA RNA protein) or backward (protein RNA DNA) strategies but the latter looks more promising because it provides a possibility for systemic analysis of the gene expression, respective regulatory networks, and effect of genegene and gene-environment interactions on the onset of a complex trait (Lei et al, 2005). Ultimately, such a combined approach should open a new avenue in the efforts towards determining a genetic basis of menarche and its timing.…”
Section: Prospects For Research On Genetics Of Age At Menarchementioning
confidence: 99%